By MarketWatch |
March 18, 2020
AbbVie Inc. and Allergan PLC announced Tuesday that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to selling some properties if they commence a planned merger.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.